428 related articles for article (PubMed ID: 2431484)
21. Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1.
Terwilliger EF; Langhoff E; Gabuzda D; Zazopoulos E; Haseltine WA
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10971-5. PubMed ID: 1720558
[TBL] [Abstract][Full Text] [Related]
22. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; Napoé G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
[TBL] [Abstract][Full Text] [Related]
23. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.
Mackewicz CE; Blackbourn DJ; Levy JA
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2308-12. PubMed ID: 7534418
[TBL] [Abstract][Full Text] [Related]
24. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.
Koenig S; Earl P; Powell D; Pantaleo G; Merli S; Moss B; Fauci AS
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8638-42. PubMed ID: 2460873
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
Joseph A; Zheng JH; Follenzi A; Dilorenzo T; Sango K; Hyman J; Chen K; Piechocka-Trocha A; Brander C; Hooijberg E; Vignali DA; Walker BD; Goldstein H
J Virol; 2008 Mar; 82(6):3078-89. PubMed ID: 18184707
[TBL] [Abstract][Full Text] [Related]
26. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
27. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
[TBL] [Abstract][Full Text] [Related]
28. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
Tsubota H; Lord CI; Watkins DI; Morimoto C; Letvin NL
J Exp Med; 1989 Apr; 169(4):1421-34. PubMed ID: 2784486
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys.
Powell JD; Yehuda-Cohen T; Villinger F; McClure HM; Sell KW; Ahmed-Ansari A
J Med Primatol; 1990; 19(3-4):239-49. PubMed ID: 1700128
[TBL] [Abstract][Full Text] [Related]
30. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
[TBL] [Abstract][Full Text] [Related]
31. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.
Kinter AL; Bende SM; Hardy EC; Jackson R; Fauci AS
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10985-9. PubMed ID: 7479922
[TBL] [Abstract][Full Text] [Related]
33. Modification of human immunodeficiency viral replication by pine cone extracts.
Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
[TBL] [Abstract][Full Text] [Related]
34. CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro.
Tsubota H; Ringler DJ; Kannagi M; King NW; Solomon KR; MacKey JJ; Walsh DG; Letvin NL
J Immunol; 1989 Aug; 143(3):858-63. PubMed ID: 2787348
[TBL] [Abstract][Full Text] [Related]
35. Replication of human immunodeficiency virus in HL-60 cells.
Semmel M; Macho A; Morozov V; Coulaud D; Alileche A; Plaisance S; Aguilar J; Jasmin C
Res Virol; 1992; 143(4):249-58. PubMed ID: 1384093
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
Addo MM; Yu XG; Rathod A; Cohen D; Eldridge RL; Strick D; Johnston MN; Corcoran C; Wurcel AG; Fitzpatrick CA; Feeney ME; Rodriguez WR; Basgoz N; Draenert R; Stone DR; Brander C; Goulder PJ; Rosenberg ES; Altfeld M; Walker BD
J Virol; 2003 Feb; 77(3):2081-92. PubMed ID: 12525643
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
Walker BD; Flexner C; Paradis TJ; Fuller TC; Hirsch MS; Schooley RT; Moss B
Science; 1988 Apr; 240(4848):64-6. PubMed ID: 2451288
[TBL] [Abstract][Full Text] [Related]
38. CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.
Blaak H; Boers PH; van der Ende ME; Schuitemaker H; Osterhaus AD
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):473-84. PubMed ID: 18327978
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
40. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions.
Bagasra O; Kajdacsy-Balla A; Lischner HW
Alcohol Clin Exp Res; 1989 Oct; 13(5):636-43. PubMed ID: 2574543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
